These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2785517)

  • 21. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines.
    Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.
    Giuliano M; Mastrantonio P; Giammanco A; Piscitelli A; Salmaso S; Wassilak SG
    J Pediatr; 1998 Jun; 132(6):983-8. PubMed ID: 9627590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.
    Cassone A; Ausiello CM; Urbani F; Lande R; Giuliano M; La Sala A; Piscitelli A; Salmaso S
    Arch Pediatr Adolesc Med; 1997 Mar; 151(3):283-9. PubMed ID: 9080938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.
    Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R
    Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
    Di Tommaso A; Bartalini M; Peppoloni S; Podda A; Rappuoli R; De Magistris MT
    Vaccine; 1997 Aug; 15(11):1218-24. PubMed ID: 9286047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro stimulation of human lymphocytes by Bordetella Pertussis.
    Andersen V; Hertz JB; Sorensen SF; Baekgaard P; Christensen PE; Ramhoj W; Hansen GA; Wardlaw AC; Sato Y
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):65-72. PubMed ID: 190855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine.
    Berstad AK; Oftung F; Korsvold GE; Haugen IL; Froholm LO; Holst J; Haneberg B
    Vaccine; 2000 May; 18(22):2323-30. PubMed ID: 10738087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.
    Ohman L; Willén R; Hultgren OH; Hultgren Hörnquist E
    Clin Exp Immunol; 2005 Jul; 141(1):37-46. PubMed ID: 15958068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse reactions and antibody response to an acellular pertussis toxoid vaccine in adult volunteers.
    Hederstedt B; Granström M
    Vaccine; 1989 Aug; 7(4):349-50. PubMed ID: 2815971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertussis antibodies, protection, and vaccine efficacy after household exposure.
    Storsaeter J; Blackwelder WC; Hallander HO
    Am J Dis Child; 1992 Feb; 146(2):167-72. PubMed ID: 1733145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of immunogenicity to protective potency in acellular pertussis vaccines.
    Xing D; Asokanathan C; Xu YH; Bolgiano B; Douglas-Bardsley A; Zhang S; Wang J; Corbel M
    Hum Vaccin Immunother; 2014; 10(7):2066-73. PubMed ID: 25424817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age.
    Aoyama T; Murase Y; Kato M; Iwai H; Iwata T
    Am J Dis Child; 1989 Jun; 143(6):655-9. PubMed ID: 2471406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
    Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.